Fupingzhenkang powder for treating infant rash

A technology for infants and young children, skin rashes, applied in the field of traditional Chinese medicine, can solve the problems of easy recurrence, difficult treatment, steroid hormone dermatitis, etc., achieve the effect of low raw material price, simple use method, and no side effects

Inactive Publication Date: 2016-02-17
王和清
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The main features of the onset are skin itching, burning, exudation or dryness; the secondary features are erythema, swelling, papules or telangiectasia, etc. Currently, corticosteroids are mainly used for the treatment of rashes. Although some rashes can be quickly controlled, but It is very easy to relapse after stopping the drug, and it is more serious than before, and even long-term use leads to steroid steroid dermatitis, and the treatment is more difficult

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Fupingzhenkang powder for treating rashes of infants and young children, which is made of the following raw materials in parts by weight: Kochia chinensis 5, duckweed grass 5, white fresh skin 4, cortex cortex 4, flavescens 4, comfrey 4, cicada slough 3 , Yinbupleurum 3, ebony 3, dry alum 2, cnidium 2, licorice 4, mung bean 4.

Embodiment 2

[0017] Fupingzhenkang powder for treating rashes of infants and young children, which is made of the following raw materials in parts by weight: Kochia chinensis 3, duckweed grass 5, white fresh skin 4, Phellodendron Phellodendri 4. Sophora flavescens 5, comfrey 2, cicada slough 4, silver Bupleurum 3, black plum 2, dry alum 1, cnidium 2, licorice 5, mung bean 5.

Embodiment 3

[0019] Fupingzhenkang powder for treating rashes of infants and young children, which is made of the following raw materials in parts by weight: Kochia chinensis 5, Duckweed grass 4, Baixianpi 5, Cortex Phellodendri 6. Sophora flavescens 3, comfrey 2, cicada slough 5, silver Bupleurum 3, black plum 1.8, dry alum 1.2, cnidium 2.5, licorice 3, mung bean 3.

[0020] The medicine of the present invention has been clinically tested. From February 2014 to May 2015, 68 cases of infantile rash were treated, 35 cases were treated with pure Chinese medicine, and compared with 33 cases of conventional Western medicine treatment, the results are as follows:

[0021] The 68 cases of children were all common children with acute and chronic eczema, acute and chronic urticaria, impetigo, atopic dermatitis, etc., all of which met the diagnostic criteria for rash. Among them, the age ranged from 2 to 35 months and were randomly divided into two groups. The 35 cases in the treatment group includ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to Fupingzhenkang powder for treating infant rash. The Fupingzhenkang powder is prepared from the following raw materials in parts by weight: 3 to 5 parts of fructus kochiae, 4 to 6 parts of nuphar pumilum, 3 to 6 parts of cortex dictamni, 4 to 6 parts of golden cypress, 3 to 5 parts of radix sophorae flavescentis, 2 to 4 parts of lithospermum, 2 to 5 parts of cicada slough, 2 to 5 parts of radices stellariae dichotomae, 1 to 3 parts of smoked plum, 1 to 2 parts of dried alum, 2 to 3 parts of fructus cnidii, 3 to 5 parts of liquorice and 3 to 5 parts of mung beans. The Fupingzhenkang powder provided by the invention has the advantages of convenience in use, good treatment effect, no toxic or side effect on patients, low price of the raw materials and low cost.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to Fupingxukangsan for treating rashes of infants and young children. Background technique [0002] Rash is the most common skin symptom in children's skin diseases. It is common in infants with acute and chronic eczema, acute and chronic urticaria, impetigo, atopic dermatitis and various chronic viral exanthematous diseases. In recent years, due to the development of society, changes in the environment, and changes in the living environment, some eruptive skin diseases have become more and more common. Western medicine treatment is mainly external application of some hormone plasters, although the curative effect is remarkable, it is easy to relapse, and has certain side effects. [0003] The causes of rashes in infants and young children are mostly related to dampness, heat, and toxins. On the one hand, due to congenital fetal toxins, their mothers usually...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/88A61K9/14A61P17/00A61K33/06A61K35/64
Inventor 王和清
Owner 王和清
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap